Discover content that is distributed for public review, including online articles, magazine reports, and medical journal broadcasts that provide a snapshot of AVITA Medical and our mission from the vantagepoint of researchers, clinicians, and patients throughout the world.
CONTRAINDICATIONS: RECELL® are contraindicated for treatment of infected wounds or with necrotic tissue present in the wound bed or with necrotic tissue present in the wound bed, and for patients having unstable vitiligo or a known hypersensitivity to anesthetics, adrenaline/epinephrine, povidine-iodine, or chlorhexidine solutions.
WARNINGS AND PRECAUTIONS: Regenerative Epidermal Suspension (RESTM ) prepared using the RECELL® Device should only be applied to patients from whom the original skin sample was taken. RECELL® is provided sterile and is intended for single-use. Do not use if packaging is damaged or expired. A skin sample should require between 15 and 30 minutes contact with the Enzyme. Contact in excess of 60 minutes is not recommended. RECELL® Enzyme is animal derived and freedom from infectious agents cannot be guaranteed. RESTM should be applied to a clean, dry, haemostatic vascularized wound bed.
For complete Important Safety Information refer to Instructions For Use for specific countries.
ADVERSE REACTIONS Any adverse reaction or suspected adverse reaction related to RECELL® should immediately be reported to Avita Medical.
Our portfolio is marketed under the RECELL® brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics.